calcipotriene NDC 66993-878

NDC codes

FDA NDC Directory

Product NDC (as listed)66993-878Labeler and product segments. Claims need a package NDC.

Product NDC at billing width66993-0878Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
66993-878-61	66993087861	1 TUBE in 1 CARTON (66993-878-61) / 60 g in 1 TUBEMarketed from Jul 1, 2013
66993-878-78	66993087878	1 TUBE in 1 CARTON (66993-878-78) / 120 g in 1 TUBEMarketed from Jul 1, 2013

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): calcipotriene
Generic name (nonproprietary): calcipotriene
Active ingredients: Calcipotriene — 50 ug/g
Dosage form: Ointment
Route: Topical
Labeler: Prasco Laboratories
Product type: Prescription drug
Marketing category: NDA authorized genericApplication NDA 020273
Marketing start: Jul 1, 2013
Listing expires: Dec 31, 2026
Other FDA classes: Vitamin D (Chemical structure)
Identifiers: Product ID 66993-878_701245ab-fce0-4a80-90c7-9e3cfa79a9f5SPL ID 701245ab-fce0-4a80-90c7-9e3cfa79a9f5SPL set ID fe7cd92a-f066-4c4a-80c8-e3f929ad4181RxCUI 198373UNII 143NQ3779B
Pharmacologic class: Vitamin D Analog

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Topical products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N466993087861 followed by a unit qualifier and the quantity

Package 66993-0878-61. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Aug 7, 2020.

Indications (excerpt from the label)

INDICATIONS AND USAGE Calcipotriene Ointment, 0.005%, is indicated for the treatment of plaque psoriasis in adults. The safety and effectiveness of topical calcipotriene in dermatoses other than psoriasis have not been established.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)